Deutsche Bank Maintains Buy on Gilead Sciences (GILD) after Strong Hepatitis C Combo Data
Go back to Deutsche Bank Maintains Buy on Gilead Sciences (GILD) after Strong Hepatitis C Combo Data| Abbott Laboratories (NYSE: ABT) | Delayed: 102.23 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $102.23 | 52 Week High | $46.38 | |||
| Open | $102.15 | 52 Week Low | $36.00 | |||
| Day High | $103.00 | P/E | 68.15 | |||
| Day Low | $100.33 | EPS | $1.50 | |||
| Volume | 3,461 | |||||
| Gilead Sciences (NASDAQ: GILD) | Delayed: 150.89 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $150.89 | 52 Week High | $108.63 | |||
| Open | $148.77 | 52 Week Low | $71.39 | |||
| Day High | $151.04 | P/E | 83.36 | |||
| Day Low | $146.89 | EPS | $1.81 | |||
| Volume | 2,211 | |||||
